# Pharmacotoxicology of Trichloroethylene Metabolites

> **NCT01128270** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Florida** · enrollment: 27 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Dichloroacetate environmental dose
- **DRUG:** Chloral Hydrate environmental dose
- **DRUG:** Dichloroacetate therapeutic dose
- **DRUG:** Chloral Hydrate therapeutic dose

## Key facts

- **NCT ID:** NCT01128270
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2014-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01128270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01128270, "Pharmacotoxicology of Trichloroethylene Metabolites". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01128270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*